Notes
Slide Show
Outline
1
Current Status and Future Directions in Substance Abuse Treatment for Women
  • Christine E. Grella, Ph.D.
  • UCLA Integrated Substance Abuse Programs


  • ADPA Lecture Series
  • December 14, 2007




2
Martha Washington Home, 1869
3
Federal Narcotics Farm, Lexington, KY, 1941 - 1965
4
Women & Drug-Related Crime, 1936
5
Topics
  • Epidemiological and health services research related to gender
  • Access to “special” services for women
  • Evolving treatment approaches for women
  • System-level challenges
  • Findings from a study of child-welfare involved women in substance abuse treatment
6
Epidemiological and
Health Services Research
Related to Gender
7
Prevalence of Lifetime Drug Use Disorders in U.S. Population by Gender
8
Prevalence of Past-Year Substance Use Disorders in U.S. Population by Gender
9
Treatment Access, Utilization,
and Outcomes
  • Gender differences in:
    • treatment utilization
    • pathways to treatment
    • clinical profile
    • retention
    • outcomes
10
Treatment Admissions by Gender and Year: 1994 – 2004
11
Treatment Admissions by Gender and Primary Substance of Abuse: 2004
12
Treatment Admissions by
Gender and Referral Source: 2004
13
Treatment Admissions by
Gender and Type of Payment: 2004
14
Factors Associated with Treatment Utilization in DATOS
(N = 7,652)
    • Men
  • spouse opposition to drug use
  • family assistance
  • referred by family, employer, or CJS
    • Women
  • exchanged sex for drugs or money
  • self-initiation to treatment
  • referred by social worker
  • antisocial personality disorder
  • single mother


15
Clinical Profile/Service Needs at Treatment Admission
  • Women tend to have greater severity in pre-treatment functioning:
    • addiction severity
    • co-occurring psychiatric disorders, especially mood & anxiety
    • lack of employment/vocational skills
    • childhood and adult trauma & abuse exposure
    • parenting responsibilities, involvement with child welfare
    • interpersonal problems, conflict with family
16
Treatment Retention
  • Treatment retention is greater among women mandated to treatment by CPS or CJS (Chen et al., 2004)
  • Women are retained longer in women-only programs or in programs with higher concentrations of pregnant/ parenting women (Grella, 1999; Grella, Joshi, & Hser, 2000 )
  • Longer time in residential treatment was related to better post-treatment outcomes in 3 large-scale national studies (Greenfield et al., 2004)
17
Treatment Retention in Residential Programs by Program Characteristics
18
Gender Differences in
Post-Treatment Outcomes
  • Research findings are mixed on the relationship of gender to treatment outcomes
  • Gender itself may not be a specific predictor of outcomes, however, several characteristics associated with treatment outcomes vary by gender and may have a greater impact on women:
    • Co-occurring psychiatric disorders
    • History of abuse or trauma
    • Socioeconomic status, employment
    • Parenting and childcare responsibilities

19
Gender Differences in Long-Term Outcomes: Transition Analysis
  • Women were 1/3 less likely than men to transition from recovery-to-using in a 6-year follow-up of a Chicago-based treatment cohort (N=1,202; 60% female; 89% African American)
  • Self-help participation was more strongly associated with transitions from using-to-recovery for women (OR’s: 1.9 vs. 1.5, respectively); similar to finding from a 16-year follow-up study of alcohol-dependent individuals (Timko, Finney, & Moos, 2005)
  • External mandate to treatment was 12 times stronger in predicting transitions from using-to-treatment for men than women (OR’s: 12.1 vs. 1.03, respectively)
20
Treatment Outcomes are Improved with Services that Address Women’s Needs
  • Residential programs with “live-in” accommodations for children (Hughes et al., 1995)
  • Outpatient programs that provide comprehensive services, e.g., case management, family/parenting services, mental health services, vocational services (Zlotnick et al., 1996; Brindis et al., 1997; Howell et al. 1999; Volpicelli et al., 2000)
21
Treatment Components Associated with Better Outcomes for Women
  • Review of 38 studies with randomized and non-randomized comparison group designs:
    • child care
    • prenatal care
    • women-only admissions
    • supplemental services & workshops on women’s focused topics
    • mental health services
    • comprehensive programming
22
To What Extent are “Specialized” Treatment Services/Programs for Women Available?
23
Special Services or Programs for Women
24
Transitional Services Offered by Whether Treatment Facilities Have a Women-Specific Program or Group: 2005
25
Other Services Offered by Whether Treatment Facilities Have a Women-Specific Program or Group: 2005
26
Characteristics of Private Programs With a Majority Female Caseload
  • National Treatment Center Study (N = 365)
    • provided childcare
    • had more families participating in treatment
    • treated psychiatric disorders
    • employed more counselors with MA degrees
    • received more referrals from mental health sources & fewer workplace referrals
    • accepted more clients with public insurance


27
Adoption of Women’s Health Services in Outpatient Programs, 1995 - 2000
  • Adoption of women’s health services (gyn exams, contraceptive counseling, prenatal care, physical exams, MH care, HIV testing) was associated with:
    • receipt of funding earmarked for women’s programming
    • provision of methadone treatment
    • greater percentage of staff trained to work with women (no effect of female staff or administrator)
    • private not-for-profit and public units (vs. private for-profit units); note: these units decreased over the study period examined
    • JACHO accreditation (for physical exams only)
28
Cost-Benefits of Specialized Substance Abuse Treatment for Women
  • Higher costs due to more intensive services (primarily medical, MH) and longer duration
  • Greater benefit-to-cost ratios for pregnant/parenting women treated in:
    • residential vs. outpatient programs                     (Daley et al., 2000)
    • specialized vs. standard residential programs (French et al., 2002)
    • multi-disciplinary comprehensive treatment program vs. medical treatment-as-usual        (Svikis et al., 1997)
    • no significant cost difference for trauma-informed/integrated treatment (Domino et al., 2005)


29
Summary
  • Treatment services that address women’s specific needs improve:
    • retention
    • outcomes
    • cost-benefits
  • Yet most women with substance abuse problems are not treated in women-specific or “specialized” programs


30
What are Evolving Treatment Approaches for Women?
31
 
32
Gender-Responsive Treatment
  • Relationship of substance use and gender-specific experiences in:
    • family background
    • abuse history
    • mental health
    • physical health
    • marital/relationship status
    • children & parenting
    • education & employment
    • criminal involvement
    • sexuality
33
 
34
The Women’s Recovery Group Study: 
Stage I Behavioral Therapies Development Trial
35
NIDA Clinical Trials Network:
Motivational Enhancement Therapy (MET) for Pregnant Substance Users
  • Experimental study of MET vs. standard treatment to improve treatment engagement and outcomes
  • 3 brief sessions focus on:
    • Developing rapport
    • Exploring pros and cons of using
    • Reviewing participant’s feedback on the consequences of substance use & the status of her pregnancy
    • Developing a change plan or strengthening commitment to change
36
Manual-Based Interventions that Address PTSD & Trauma Exposure
  • Seeking Safety (Najavits): 25-session cognitive, behavioral training, case management, & social support to address PTSD & substance abuse concurrently; focus on coping skills


  • Beyond Trauma: A Healing Journey for Women (Covington): cognitive-behavioral, expressive arts, & relational theory; empowerment approach for offenders
37
Implementation Challenges
  • Moving beyond one-size-fits all approach
    • differences by age, ethnicity, culture, sexual orientation
  • Treatment as a longitudinal process (e.g., chronic disease/long-term care model)
    • what is time frame for measuring change?
  • External constraints/realities (e.g., labor market & economic conditions, bureaucratic inertia, system-level mandates)
  • How to demonstrate change/progress?
    • internal evaluation capacity
    • treatment outcomes
    • performance indicators
38
System-Level Challenges
  • Treatment access & utilization
  • Systems integration
  • Cross-system evaluation of outcomes
39
 
40
Major Policy Initiatives Influence Women’s Access to AOD Treatment
  • Criminal justice:  changes in drug laws and sentencing policies have increased arrest and incarceration rates of women; drug courts; Prop 36
  • Health services:  cost-containment initiatives have reduced length of stay in treatment and service intensity; screening & brief motivational interventions in primary care & ER’s
  • Welfare:  mandated screening for AOD abuse and referral for treatment participation; time table for benefits; restrictions on entitlements
  • Child welfare:  increased emphasis on screening and assessment and coordinated treatment; time table for permanent placement (ASFA); dependency drug courts
41
Structural Barriers to Drug Treatment
  • Level of impairment must be high to reach treatment through institutional channels
  • Lack of treatment availability, particularly in residential programs with capacity for child “live-in” and outpatient programs that provide child-care or family-related services
  • Lack of co-ordination among substance abuse, health care, mental health, criminal justice, and child welfare systems
42
Child Welfare System
43
 
44
Relationship of Treatment Participation and Child Welfare Outcomes
  • A recent study comparing placement outcomes of children of substance-abusing mothers, pre- and post-ASFA, showed that they:
    • spent less time in foster care
    • were placed more quickly into permanent placements
    • were more likely to be adopted than to remain in long-term foster care
    • however, the proportion of children who were reunified remained the same
45
Comparison of Mothers Based on Child Welfare Involvement in a Statewide Treatment Outcome Study
  • Younger (31.6 vs. 34.4)
  • More children (2.93 vs. 2.09)
  • More methamphetamine use (47% vs. 37%)
  • More likely to have history of physical abuse
  • More economic instability:
    • higher ASI Employment Score
    • less likely to have HS degree (50% vs. 66%)
    • less likely to be in labor force (18% vs. 26%)
    • more likely to depend on others for support (45% vs. 39%)
  • Higher scores on ASI Alcohol Score
  • More polysubstance use (61% vs. 53%)
  • More likely to be referred by self or family (35% vs. 25%) and less likely to be referred by a service provider (15% vs. 28%)
46
Multi-Level Model of Factors Associated with Child Reunification Following Mother’s Participation in  Treatment
47
Child Characteristics Associated with Reunification
  • Older vs. younger ageÃ
  • Non-kin placement (e.g., foster or group home) vs. kin placementÃ



48
Mother Characteristics Associated with Reunification
  • Referral for AOD services in CWS records (OR = 1.50)Ã
  • Treatment completion (OR = 1.95)Ã
49
Program-Level Predictors of Reunification
50
Conclusion
  • Treatment for substance use disorders among women is most effective when it addresses the broad range of issues that accompany substance use among women (e.g., mental health, trauma, parenting, lack of economic self-sufficiency, relationships)
  • Current evidence-based treatment approaches have the potential to address the unique treatment needs & issues of women, but evaluations of the efficacy of these gender-responsive approaches are still in the early stages
  • Referral and/or treatment for substance use disorders is increasingly embedded within other service systems (rather than in stand-alone programs) and necessitates a cross-system team approach